Article Versions Notes

Joo H, Oh M-K, Kang JY, Park HS, Chae D-H, Kim J, Lee J-H, Yoo HM, Choi U, Kim D-K, et al. Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties. Biomedicines. 2021; 9(2):209. https://doi.org/10.3390/biomedicines9020209

Joo, Hansol, Mi-Kyung Oh, Ji Yeon Kang, Hyun Sung Park, Dong-Hoon Chae, Jieun Kim, Jong-Hee Lee, Hee Min Yoo, Uimook Choi, Do-Kyun Kim, and et al. 2021. "Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties" Biomedicines 9, no. 2: 209. https://doi.org/10.3390/biomedicines9020209

Joo, H., Oh, M.-K., Kang, J. Y., Park, H. S., Chae, D.-H., Kim, J., Lee, J.-H., Yoo, H. M., Choi, U., Kim, D.-K., Lee, H., Kim, S., & Yu, K.-R. (2021). Extracellular Vesicles from Thapsigargin-Treated Mesenchymal Stem Cells Ameliorated Experimental Colitis via Enhanced Immunomodulatory Properties. Biomedicines, 9(2), 209. https://doi.org/10.3390/biomedicines9020209